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Recent findings suggest an important role of neuroinflammation in neurodegenerative 
diseases, such as Alzheimer’s disease and Parkinson’s disease, which are debilitating, 
expensive and largely untreatable conditions strongly linked with age. Microglia are the 
innate immune cells of the brain that, under homeostatic conditions, constantly survey 
their environment and prune neuronal synapses. Following an insult or injury, these 
cells become activated and can perform a wide array of functions by production of pro-
inflammatory and neurotoxic factors, as well as protective, anti-inflammatory and 
phagocytic functions. In chronic neuroinflammatory states seen in neurodegenerative 
diseases a unique disease-associated phenotype is observed. Selective mutations in 
microglia/myeloid-specific genes, including the glycoprotein triggering receptor on 
myeloid cells 2 (TREM2), have been associated with Alzheimer’s disease. Recent 
evidences have suggested TREM2 to be instrumental in neuroinflammation and linked 
to microglia neurodegenerative/disease-associated phenotype. One protein which 
induces this phenotype is galectin-3, which binds complex glycans in glycoproteins. 
Galectin-3 is expressed and released specifically by highly activated microglia in the 
injured brain and can propagate inflammation by binding glycoproteins such as TLR4, 
and also TREM2. In this presentation I will address whether galectin-3 also contributes 
to detrimental neuroinflammation in Alzheimer’s pathology, and, hence, could be a 
therapeutic target. 
 
 
 
